Opiant's nasal opioid overdose drug boards FDA fast track
To view this email as a web page, click here

Today's Rundown

Featured Story

Sanofi, Roche team up to drive adoption of smart insulin pen

Sanofi and Roche have joined forces in France, teaming up to drive adoption of a connected add-on for disposable insulin pens. The partners will jointly develop a scientific program for physicians and retail pharmacists around the Biocorp product.

read more

Top Stories

With subcut Darzalex driving growth, Halozyme eyes role for drug delivery tech in cell therapies

Halozyme Therapeutics has outlined plans to expand use of its Enhanze drug delivery technology, branching out beyond antibodies to cover small molecules and cell therapies.

read more

With filing in sight, Opiant's nasal opioid overdose drug boards FDA fast track

Opiant Pharmaceuticals has landed fast-track designation for its nasal nalmefene formulation, teeing it up to benefit from close communication with the FDA as it prepares to seek approval for the opioid overdose drug in the coming months.

read more

Improving immunotherapy delivery by bringing order to tumor blood vessels

The leaky, disorganized mess of blood vessels that support tumors can stop drugs from reaching their targets and thereby nullify their impact. Recognizing that, researchers have identified a way to bring order to the blood vessels—and thereby enable drugs to reach their targets in the tumor.

read more

Fierce Biotech’s Rotten Tomatoes 2021

The biopharma industry has received acclaim during the COVID-19 pandemic. But while some companies have been working hard on life-saving therapies, others' actions have further stained the industry's already shaky reputation.

read more

Resources

Whitepaper: Create a seamless experience across eConsent, eCOA & more

Find out how to improve clinical protocol adherence, and thus patient outcomes, by 15%+ with Medable’s latest White Paper.

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

Whitepaper: How the Chronic Insomnia Market Raises Big Questions About Digital Therapeutics

Paper describing how the chronic insomnia market offers big lessons for any biopharma company thinking about getting into digital therapeutics in any therapeutic area.

Whitepaper: A Checklist for eCOA Solution Deployment

Every detail is important when selecting a new eCOA solution; learn more about the current eCOA landscape, best practices, and crucial considerations for successful eCOA solution deployment in this white paper.

2021 Report: Clinical Trial Management in a Post-Pandemic World

New market research provides valuable insight into the impact of adaptations made in clinical trials during the pandemic.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Content Hub: Remarque Systems Resource Hub

Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. 

Events